These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 31529852

  • 1. Multidrug resistance and risk factors associated with community-acquired urinary tract infections caused by Escherichia coli in Venezuela.
    Guzmán M, Salazar E, Cordero V, Castro A, Villanueva A, Rodulfo H, De Donato M.
    Biomedica; 2019 May 01; 39(s1):96-107. PubMed ID: 31529852
    [Abstract] [Full Text] [Related]

  • 2. Prevalence and types of extended spectrum β-lactamases among urinary Escherichia coli isolates in Moroccan community.
    Barguigua A, El Otmani F, Talmi M, Zerouali K, Timinouni M.
    Microb Pathog; 2013 May 01; 61-62():16-22. PubMed ID: 23643553
    [Abstract] [Full Text] [Related]

  • 3. Molecular characteristics and antibiotic resistance profiles of Escherichia coli strains isolated from urinary tract infections in children admitted to children's referral hospital of Qom, Iran.
    Pourakbari B, Mamishi S, Shokrollahi MR, Heydari H, Mahmoudi S, Banar M, Sadeghi RH, Movahedi Z.
    Ann Ig; 2019 May 01; 31(3):252-262. PubMed ID: 31069370
    [Abstract] [Full Text] [Related]

  • 4. [Prevalence of beta-lactamase CTX-M-15 in phylogenetic groups of uropathogenic Escherichia coli isolated from patients in the community of Merida, Venezuela].
    Hernández E, Araque M, Millán Y, Millán B, Vielma S.
    Invest Clin; 2014 Mar 01; 55(1):32-43. PubMed ID: 24758100
    [Abstract] [Full Text] [Related]

  • 5. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E, Romaní V, Xercavins M, Gómez L, Vidal CG, Quintana S, Vila J, Garau J.
    J Antimicrob Chemother; 2006 Apr 01; 57(4):780-3. PubMed ID: 16492721
    [Abstract] [Full Text] [Related]

  • 6. Antimicrobial Resistance and Molecular Characterization of Extended-Spectrum β-Lactamases of Escherichia coli and Klebsiella spp. Isolates from Urinary Tract Infections in Southern Brazil.
    Pereira JL, Volcão LM, Klafke GB, Vieira RS, Gonçalves CV, Ramis IB, da Silva PEA, von Groll A.
    Microb Drug Resist; 2019 Mar 01; 25(2):173-181. PubMed ID: 30133334
    [Abstract] [Full Text] [Related]

  • 7. Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections.
    Smet A, Martel A, Persoons D, Dewulf J, Heyndrickx M, Claeys G, Lontie M, Van Meensel B, Herman L, Haesebrouck F, Butaye P.
    Microb Drug Resist; 2010 Jun 01; 16(2):129-34. PubMed ID: 20370505
    [Abstract] [Full Text] [Related]

  • 8. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
    Drinkovic D, Morris AJ, Dyet K, Bakker S, Heffernan H.
    N Z Med J; 2015 Mar 13; 128(1410):50-9. PubMed ID: 25829039
    [Abstract] [Full Text] [Related]

  • 9. Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large U.S. Medical Center.
    Hayakawa K, Gattu S, Marchaim D, Bhargava A, Palla M, Alshabani K, Gudur UM, Pulluru H, Bathina P, Sundaragiri PR, Sarkar M, Kakarlapudi H, Ramasamy B, Nanjireddy P, Mohin S, Dasagi M, Datla S, Kuchipudi V, Reddy S, Shahani S, Upputuri V, Marrey S, Gannamani V, Madhanagopal N, Annangi S, Sudha B, Muppavarapu KS, Moshos JA, Lephart PR, Pogue JM, Bush K, Kaye KS.
    Antimicrob Agents Chemother; 2013 Aug 13; 57(8):4010-8. PubMed ID: 23752516
    [Abstract] [Full Text] [Related]

  • 10. Emergence of extended spectrum-β-lactamase-producing Escherichia coli O25b-ST131: a major community-acquired uropathogen in infants.
    Cheng MF, Chen WL, Hung WY, Huang IF, Chiou YH, Chen YS, Lee SS, Hung CH, Wang JL.
    Pediatr Infect Dis J; 2015 May 13; 34(5):469-75. PubMed ID: 25879646
    [Abstract] [Full Text] [Related]

  • 11. Prevalence and quinolone resistance of fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli in 6 communities and 2 physical examination center populations in Shanghai, China.
    Ni Q, Tian Y, Zhang L, Jiang C, Dong D, Li Z, Mao E, Peng Y.
    Diagn Microbiol Infect Dis; 2016 Dec 13; 86(4):428-433. PubMed ID: 27681363
    [Abstract] [Full Text] [Related]

  • 12. Molecular characterization of Extended-spectrum β lactamase- producing E. coli recovered from community-acquired urinary tract infections in Upper Egypt.
    Hassuna NA, Khairalla AS, Farahat EM, Hammad AM, Abdel-Fattah M.
    Sci Rep; 2020 Feb 17; 10(1):2772. PubMed ID: 32066805
    [Abstract] [Full Text] [Related]

  • 13. [Prevalence and risk factors for extended-spectrum β-lactamase-producing Escherichia coli causing community-onset urinary tract infections in Colombia].
    Blanco VM, Maya JJ, Correa A, Perenguez M, Muñoz JS, Motoa G, Pallares CJ, Rosso F, Matta L, Celis Y, Garzon M, Villegas MV.
    Enferm Infecc Microbiol Clin; 2016 Nov 17; 34(9):559-565. PubMed ID: 26774256
    [Abstract] [Full Text] [Related]

  • 14. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children.
    Fan NC, Chen HH, Chen CL, Ou LS, Lin TY, Tsai MH, Chiu CH.
    J Microbiol Immunol Infect; 2014 Oct 17; 47(5):399-405. PubMed ID: 23834784
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of fluoroquinolone-resistant and broad-spectrum cephalosporin-resistant community-acquired urinary tract infections in Rio de Janeiro: Impact of Escherichia coli genotypes ST69 and ST131.
    de Souza da-Silva AP, de Sousa VS, de Araújo Longo LG, Caldera S, Baltazar ICL, Bonelli RR, Santoro-Lopes G, Riley LW, Moreira BM.
    Infect Genet Evol; 2020 Nov 17; 85():104452. PubMed ID: 32634601
    [Abstract] [Full Text] [Related]

  • 16. Multidrug resistance dissemination by extended-spectrum β-lactamase-producing Escherichia coli causing community-acquired urinary tract infection in the Central-Western Region, Brazil.
    Gonçalves LF, de Oliveira Martins-Júnior P, de Melo ABF, da Silva RCRM, de Paulo Martins V, Pitondo-Silva A, de Campos TA.
    J Glob Antimicrob Resist; 2016 Sep 17; 6():1-4. PubMed ID: 27530830
    [Abstract] [Full Text] [Related]

  • 17. High prevalence of ST131 among CTX-M-producing Escherichia coli from community-acquired infections, in the Czech Republic.
    Papagiannitsis CC, Študentová V, Jakubů V, Španělová P, Urbášková P, Žemličková H, Hrabák J.
    Microb Drug Resist; 2015 Feb 17; 21(1):74-84. PubMed ID: 25188031
    [Abstract] [Full Text] [Related]

  • 18. Community emergence of CTX-M type extended-spectrum beta-lactamases among urinary Escherichia coli from women.
    Ho PL, Poon WW, Loke SL, Leung MS, Chow KH, Wong RC, Yip KS, Lai EL, Tsang KW, COMBAT study group.
    J Antimicrob Chemother; 2007 Jul 17; 60(1):140-4. PubMed ID: 17496058
    [Abstract] [Full Text] [Related]

  • 19. Distribution of ESBLs among Escherichia coli isolates from outpatients with recurrent UTIs and their antimicrobial resistance.
    Al-Mayahie S, Al Kuriashy JJ.
    J Infect Dev Ctries; 2016 Jun 30; 10(6):575-83. PubMed ID: 27367005
    [Abstract] [Full Text] [Related]

  • 20. Comparison of quinolone and beta-lactam resistance among Escherichia coli strains isolated from urinary tract infections.
    Tayebi Z, Heidari H, Kazemian H, Ghafoori SM, Boroumandi S, Houri H.
    Infez Med; 2016 Dec 01; 24(4):326-330. PubMed ID: 28011969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.